Portfolio Holdings Detail for ISIN IE00B43HR379
Stock Name / Fund iShares S&P 500 Health Care Sector UCITS ETF USD (Acc)
Issuer Blackrock
Entity holding fund iShares V Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300QETNU1W5JY7Z94
ETF Ticker IHCU(GBX) LSE
ETF Ticker IUHC(USD) LSE
ETF Ticker QDVG(EUR) F
ETF Ticker IHCU.LS(GBX) CXE
ETF Ticker IUHC.LS(USD) CXE
ETF Ticker IUHCz(USD) CXE
ETF Ticker QDVG.DE(EUR) CXE
ETF Ticker IHCU.L(GBP) LSE
ETF Ticker IUHC.L(GBP) LSE

Holdings detail for EW

Stock Name	Edwards Lifesciences Corp
Ticker	EW(USD) NYSE
TYPE	Common Stock
Country	USA
ISIN	US28176E1082
LEI	YA13X31F3V31L8TMPR58

Show aggregate EW holdings

News associated with EW

Edwards Lifesciences (NYSE:EW) Cut to Buy at Wall Street Zen: Edwards Lifesciences (NYSE:EW – Get Free Report) was downgraded by analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a note issued to investors on Saturday. A number of other research analysts have also issued reports on the company. Wells Fargo & Company boosted their price objective on Edwards Lifesciences […] - 2025-09-15 05:40:50
Here Are Billionaire Ken Griffin's 5 Biggest Stock Holdings: Key PointsKen Griffin founded the hedge fund firm Citadel. - 2025-09-09 12:44:48
Top Stock Reports for Apple, Novartis & Charles Schwab: Apple grows Services to 1B+ paid subscribers, while Novartis lifts guidance and Schwab rides higher rates to asset gains. - 2025-09-04 17:29:00
Atria Wealth Solutions Inc. Sells 29,763 Shares of Edwards Lifesciences Corporation (NYSE:EW): Atria Wealth Solutions Inc. cut its position in shares of Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 81.7% during the 1st quarter, HoldingsChannel reports. The firm owned 6,662 shares of the medical research company’s stock after selling 29,763 shares during the period. Atria Wealth Solutions Inc.’s holdings in Edwards Lifesciences were worth $483,000 as […] - 2025-08-14 05:04:55
Edwards Lifesciences (NYSE:EW) Raised to Buy at BTIG Research: Edwards Lifesciences (NYSE:EW – Get Free Report) was upgraded by investment analysts at BTIG Research from a “neutral” rating to a “buy” rating in a note issued to investors on Tuesday, Marketbeat reports. The firm currently has a $100.00 target price on the medical research company’s stock. BTIG Research’s price target points to a potential […] - 2025-07-31 03:02:52
Edwards Lifesciences (NYSE:EW) Upgraded at Wall Street Zen: Wall Street Zen upgraded shares of Edwards Lifesciences (NYSE:EW – Free Report) from a hold rating to a buy rating in a research note issued to investors on Saturday. Several other research analysts have also weighed in on EW. Wells Fargo & Company lifted their price objective on Edwards Lifesciences from $80.00 to $84.00 and […] - 2025-07-29 02:58:49
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 13:25:48
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 12:26:28
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 09:49:10
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 08:57:30
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 07:43:41
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 04:16:07
Edwards Lifesciences (NYSE:EW) Price Target Raised to $82.00: Edwards Lifesciences (NYSE:EW – Free Report) had its price objective upped by Truist Financial from $81.00 to $82.00 in a research note published on Friday,Benzinga reports. They currently have a hold rating on the medical research company’s stock. A number of other research firms have also weighed in on EW. Wall Street Zen lowered shares […] - 2025-07-28 04:08:50
Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says: Edwards Lifesciences (NYSE:EW – Free Report) had its price target increased by JPMorgan Chase & Co. from $80.00 to $85.00 in a report published on Friday morning,Benzinga reports. JPMorgan Chase & Co. currently has a neutral rating on the medical research company’s stock. Several other brokerages also recently issued reports on EW. Wells Fargo & […] - 2025-07-28 04:08:48
Edwards Lifesciences (NYSE:EW) Price Target Raised to $95.00: Edwards Lifesciences (NYSE:EW – Free Report) had its price target raised by Barclays from $90.00 to $95.00 in a report published on Friday,Benzinga reports. Barclays currently has an overweight rating on the medical research company’s stock. A number of other equities analysts have also weighed in on the stock. Deutsche Bank Aktiengesellschaft lifted their price […] - 2025-07-28 02:46:53
Stifel Nicolaus Issues Positive Forecast for Edwards Lifesciences (NYSE:EW) Stock Price: Edwards Lifesciences (NYSE:EW – Free Report) had its target price upped by Stifel Nicolaus from $90.00 to $95.00 in a research report sent to investors on Friday morning,Benzinga reports. The brokerage currently has a buy rating on the medical research company’s stock. EW has been the topic of several other research reports. Evercore ISI increased […] - 2025-07-28 02:46:53
Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, Robert W. Baird Analyst Says: Edwards Lifesciences (NYSE:EW – Free Report) had its target price boosted by Robert W. Baird from $78.00 to $79.00 in a research report report published on Friday morning,Benzinga reports. Robert W. Baird currently has a neutral rating on the medical research company’s stock. Other research analysts have also issued reports about the stock. Evercore ISI […] - 2025-07-28 02:46:51
Edwards Lifesciences (NYSE:EW) Price Target Raised to $80.00: Edwards Lifesciences (NYSE:EW – Free Report) had its target price lifted by Evercore ISI from $77.00 to $80.00 in a research report report published on Friday,Benzinga reports. The firm currently has an in-line rating on the medical research company’s stock. A number of other brokerages have also issued reports on EW. Argus upgraded shares of […] - 2025-07-28 02:46:51
Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says: Edwards Lifesciences (NYSE:EW – Free Report) had its price objective lifted by Wells Fargo & Company from $80.00 to $84.00 in a report released on Friday morning,Benzinga reports. They currently have an overweight rating on the medical research company’s stock. A number of other research analysts also recently commented on EW. Dbs Bank raised shares […] - 2025-07-28 02:46:49
Deutsche Bank Aktiengesellschaft Issues Positive Forecast for Edwards Lifesciences (NYSE:EW) Stock Price: Edwards Lifesciences (NYSE:EW – Free Report) had its price objective increased by Deutsche Bank Aktiengesellschaft from $85.00 to $94.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage currently has a buy rating on the medical research company’s stock. Several other equities analysts have also issued reports on EW. Dbs Bank upgraded […] - 2025-07-28 02:46:49
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 02:37:03
Solid Corporate Earnings Results Support Stocks: The S&P 500 Index ($SPX ) (SPY ) today is up +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.19%. September E-mini S&P futures (ESU25 ) are up +0.18%, and September E-mini Nasdaq futures... - 2025-07-25 19:42:53
Solid Corporate Earnings Results Support Stocks: The S&P 500 Index ($SPX ) (SPY ) today is up +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.19%. September E-mini S&P futures (ESU25 ) are up +0.18%, and September E-mini Nasdaq futures... - 2025-07-25 14:56:19
Positive Earnings Results Lift Stocks: The S&P 500 Index ($SPX ) (SPY ) today is up +0.14%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.13%. September E-mini S&P futures (ESU25 ) are up +0.10%, and September E-mini Nasdaq futures... - 2025-07-25 14:23:43
Solid Corporate Earnings Results Support Stocks: The S&P 500 Index ($SPX ) (SPY ) today is up +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.19%. September E-mini S&P futures (ESU25 ) are up +0.18%, and September E-mini Nasdaq futures... - 2025-07-25 14:18:44
Positive Earnings Results Lift Stocks: The S&P 500 Index ($SPX ) (SPY ) today is up +0.14%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.13%. September E-mini S&P futures (ESU25 ) are up +0.10%, and September E-mini Nasdaq futures... - 2025-07-25 12:39:11
J.W. Cole Advisors Inc. Has $814,000 Stock Holdings in Edwards Lifesciences Corporation (NYSE:EW): J.W. Cole Advisors Inc. raised its holdings in Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 220.2% in the 1st quarter, HoldingsChannel reports. The fund owned 11,224 shares of the medical research company’s stock after acquiring an additional 7,719 shares during the period. J.W. Cole Advisors Inc.’s holdings in Edwards Lifesciences were worth $814,000 at […] - 2025-07-25 05:12:50
Sigma Planning Corp Has $294,000 Position in Edwards Lifesciences Corporation (NYSE:EW): Sigma Planning Corp boosted its holdings in Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 4.9% in the 1st quarter, HoldingsChannel.com reports. The firm owned 4,055 shares of the medical research company’s stock after acquiring an additional 191 shares during the quarter. Sigma Planning Corp’s holdings in Edwards Lifesciences were worth $294,000 as of its […] - 2025-07-21 05:06:55
Edwards Lifesciences Corporation (NYSE:EW) Position Lowered by Ballentine Partners LLC: Ballentine Partners LLC decreased its stake in shares of Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 6.8% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 5,109 shares of the medical research company’s stock after selling 375 shares during the period. Ballentine Partners LLC’s holdings […] - 2025-07-16 06:51:32
Alps Advisors Inc. Purchases Shares of 5,090 Edwards Lifesciences Corporation (NYSE:EW): Alps Advisors Inc. bought a new position in Edwards Lifesciences Corporation (NYSE:EW – Free Report) during the 1st quarter, HoldingsChannel reports. The fund bought 5,090 shares of the medical research company’s stock, valued at approximately $369,000. A number of other hedge funds have also recently added to or reduced their stakes in the stock. Norges […] - 2025-07-16 06:01:07

iShares S&P 500 Health Care Sector UCITS ETF USD (Acc) EW holdings

Date	Number of EW Shares Held	Base Market Value of EW Shares	Local Market Value of EW Shares	Change in EW Shares Held	Change in EW Base Value	Current Price per EW Share Held	Previous Price per EW Share Held
2025-10-16 (Thursday)	291,717	USD 21,193,240	USD 21,193,240
2025-10-15 (Wednesday)	290,072	USD 21,154,951	USD 21,154,951
2025-10-14 (Tuesday)	287,769	USD 21,110,734	USD 21,110,734
2025-10-13 (Monday)	287,440	USD 20,968,748	USD 20,968,748
2025-10-08 (Wednesday)	284,150	USD 21,521,521	USD 21,521,521
2025-10-07 (Tuesday)	283,163	USD 21,724,265	USD 21,724,265	0	USD 45,306	USD 76.72	USD 76.56
2025-10-06 (Monday)	283,163	USD 21,678,959	USD 21,678,959	1,645	USD -17,633	USD 76.56	USD 77.07
2025-10-03 (Friday)	281,518	USD 21,696,592	USD 21,696,592	646	USD 167,753	USD 77.07	USD 76.65
2025-10-02 (Thursday)	280,872	USD 21,528,839	USD 21,528,839	323	USD 120,145	USD 76.65	USD 76.31
2025-10-01 (Wednesday)	280,549	USD 21,408,694	USD 21,408,694	1,884	USD -263,083	USD 76.31	USD 77.77

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of EW by Blackrock for IE00B43HR379

Show aggregate share trades of EW

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-10-06 BUY 1,645 76.560* 73.25
2025-10-03 BUY 646 77.070* 73.23
2025-10-02 BUY 323 76.650* 73.21
2025-10-01 BUY 1,884 76.310* 73.19
2025-09-24 BUY 2,501 74.660* 73.11
2025-09-18 BUY 323 74.550* 73.10
2025-09-11 BUY 322 78.010* 73.05
2025-09-10 BUY 322 78.280* 73.02
2025-08-20 BUY 640 81.390* 72.79
2025-08-19 BUY 320 78.930* 72.76
2025-07-17 SELL -326 76.180* 72.67 Profit of 23,690 on sale
2025-07-15 SELL -1,304 76.810* 72.62 Profit of 94,700 on sale
2025-07-14 SELL -3,260 78.280* 72.59 Profit of 236,637 on sale
2025-07-09 SELL -326 77.190* 72.49 Profit of 23,631 on sale
2025-07-07 SELL -652 76.690* 72.44 Profit of 47,228 on sale
2025-07-02 BUY 326 77.020* 72.35
2025-06-24 SELL -5,542 75.850* 72.19 Profit of 400,065 on sale
2025-06-23 BUY 326 75.320* 72.17
2025-06-20 SELL -652 73.830* 72.16 Profit of 47,046 on sale
2025-06-18 SELL -326 73.980* 72.13 Profit of 23,515 on sale
2025-06-17 BUY 3,912 73.270* 72.12
2025-06-13 SELL -652 75.150* 72.08 Profit of 46,998 on sale
2025-06-11 SELL -326 75.470* 72.03 Profit of 23,483 on sale
2025-06-10 SELL -652 75.800* 72.01 Profit of 46,948 on sale
2025-06-09 SELL -978 76.360* 71.97 Profit of 70,391 on sale
2025-05-21 SELL -324 76.100* 71.48 Profit of 23,159 on sale
2025-05-20 SELL -648 77.830* 71.43 Profit of 46,286 on sale
2025-05-15 SELL -972 76.880* 71.28 Profit of 69,281 on sale
2025-05-14 SELL -972 76.750* 71.23 Profit of 69,238 on sale
2025-05-13 BUY 324 75.500* 71.20
2025-05-09 SELL -324 73.680* 71.15 Profit of 23,051 on sale
2025-05-08 BUY 646 74.630* 71.12
2025-05-01 BUY 646 75.180* 70.94
2025-04-24 SELL -323 75.130* 70.72 Profit of 22,841 on sale
2025-04-23 BUY 969 70.460* 70.72
2025-04-15 SELL -323 70.760* 70.71 Profit of 22,840 on sale
2025-04-10 SELL -640 68.260* 70.76 Profit of 45,287 on sale
2025-04-08 SELL -320 67.070* 70.81 Profit of 22,658 on sale
2025-04-07 SELL -320 69.000* 70.83 Profit of 22,665 on sale
2025-04-04 SELL -640 69.360* 70.84 Profit of 45,339 on sale
2025-04-02 BUY 320 72.050* 70.83
2025-04-01 BUY 2,880 71.870* 70.82
2025-03-31 SELL -1,926 72.480* 70.80 Profit of 136,361 on sale
2025-03-28 BUY 320 70.910* 70.80
2025-03-26 SELL -203 71.090* 70.79 Profit of 14,371 on sale
2025-03-21 BUY 5,057 70.460* 70.78
2025-03-20 BUY 1,272 70.950* 70.78
2025-03-17 SELL -318 70.630* 70.79 Profit of 22,510 on sale
2025-03-12 SELL -1,805 68.510* 70.87 Profit of 127,923 on sale
2025-03-07 BUY 323 70.330* 70.94
2025-02-28 SELL -969 71.620* 70.89 Profit of 68,697 on sale
2025-02-25 BUY 3,220 71.450* 70.86
2025-02-20 BUY 2,254 74.710* 70.74
2025-02-19 BUY 966 74.670* 70.68
2025-02-18 BUY 644 75.670* 70.60
2025-02-13 BUY 1,605 76.000* 70.32
2025-02-04 BUY 1,284 71.330* 70.12
2025-01-31 BUY 321 72.450* 70.05
2025-01-29 BUY 321 71.130* 69.97
2025-01-27 BUY 642 69.200* 69.93
2025-01-24 BUY 321 68.990* 69.95
2025-01-22 BUY 1,284 69.040* 69.99
2024-12-10 SELL -322 73.390* 69.48 Profit of 22,372 on sale
2024-12-09 SELL -8,372 70.900* 69.43 Profit of 581,299 on sale
2024-12-03 SELL -3,864 70.200* 69.05 Profit of 266,826 on sale
2024-12-02 SELL -1,610 70.530* 69.00 Profit of 111,089 on sale
2024-11-29 SELL -3,235 71.350* 68.91 Profit of 222,921 on sale
2024-11-22 SELL -3,250 70.480* 68.30 Profit of 221,960 on sale
2024-11-21 SELL -1,625 70.380* 68.19 Profit of 110,810 on sale
2024-11-20 BUY 2,600 69.540* 68.12
2024-11-18 SELL -3,900 69.890* 67.89 Profit of 264,785 on sale
2024-11-11 BUY 2,925 66.700* 68.11
2024-11-08 SELL -10,336 66.230* 68.25 Profit of 705,395 on sale
2024-11-07 SELL -644 65.840* 68.43 Profit of 44,070 on sale
2024-11-01 SELL -644 67.540* 69.24 Profit of 44,591 on sale
2024-10-31 SELL -1,300 67.010* 69.52 Profit of 90,374 on sale
2024-10-30 BUY 325 68.630* 69.65
2024-10-29 BUY 1,950 69.370* 69.69
2024-10-28 SELL -975 68.520* 69.93 Profit of 68,178 on sale
Market high and low price is on the date.

Date	Action	Quantity	Likely Trade Price	Average Price previous trades
2025-10-06	BUY	1,645	76.560*	73.25
2025-10-03	BUY	646	77.070*	73.23
2025-10-02	BUY	323	76.650*	73.21
2025-10-01	BUY	1,884	76.310*	73.19
2025-09-24	BUY	2,501	74.660*	73.11
2025-09-18	BUY	323	74.550*	73.10
2025-09-11	BUY	322	78.010*	73.05
2025-09-10	BUY	322	78.280*	73.02
2025-08-20	BUY	640	81.390*	72.79
2025-08-19	BUY	320	78.930*	72.76
2025-07-17	SELL	-326	76.180*	72.67 Profit of 23,690 on sale
2025-07-15	SELL	-1,304	76.810*	72.62 Profit of 94,700 on sale
2025-07-14	SELL	-3,260	78.280*	72.59 Profit of 236,637 on sale
2025-07-09	SELL	-326	77.190*	72.49 Profit of 23,631 on sale
2025-07-07	SELL	-652	76.690*	72.44 Profit of 47,228 on sale
2025-07-02	BUY	326	77.020*	72.35
2025-06-24	SELL	-5,542	75.850*	72.19 Profit of 400,065 on sale
2025-06-23	BUY	326	75.320*	72.17
2025-06-20	SELL	-652	73.830*	72.16 Profit of 47,046 on sale
2025-06-18	SELL	-326	73.980*	72.13 Profit of 23,515 on sale
2025-06-17	BUY	3,912	73.270*	72.12
2025-06-13	SELL	-652	75.150*	72.08 Profit of 46,998 on sale
2025-06-11	SELL	-326	75.470*	72.03 Profit of 23,483 on sale
2025-06-10	SELL	-652	75.800*	72.01 Profit of 46,948 on sale
2025-06-09	SELL	-978	76.360*	71.97 Profit of 70,391 on sale
2025-05-21	SELL	-324	76.100*	71.48 Profit of 23,159 on sale
2025-05-20	SELL	-648	77.830*	71.43 Profit of 46,286 on sale
2025-05-15	SELL	-972	76.880*	71.28 Profit of 69,281 on sale
2025-05-14	SELL	-972	76.750*	71.23 Profit of 69,238 on sale
2025-05-13	BUY	324	75.500*	71.20
2025-05-09	SELL	-324	73.680*	71.15 Profit of 23,051 on sale
2025-05-08	BUY	646	74.630*	71.12
2025-05-01	BUY	646	75.180*	70.94
2025-04-24	SELL	-323	75.130*	70.72 Profit of 22,841 on sale
2025-04-23	BUY	969	70.460*	70.72
2025-04-15	SELL	-323	70.760*	70.71 Profit of 22,840 on sale
2025-04-10	SELL	-640	68.260*	70.76 Profit of 45,287 on sale
2025-04-08	SELL	-320	67.070*	70.81 Profit of 22,658 on sale
2025-04-07	SELL	-320	69.000*	70.83 Profit of 22,665 on sale
2025-04-04	SELL	-640	69.360*	70.84 Profit of 45,339 on sale
2025-04-02	BUY	320	72.050*	70.83
2025-04-01	BUY	2,880	71.870*	70.82
2025-03-31	SELL	-1,926	72.480*	70.80 Profit of 136,361 on sale
2025-03-28	BUY	320	70.910*	70.80
2025-03-26	SELL	-203	71.090*	70.79 Profit of 14,371 on sale
2025-03-21	BUY	5,057	70.460*	70.78
2025-03-20	BUY	1,272	70.950*	70.78
2025-03-17	SELL	-318	70.630*	70.79 Profit of 22,510 on sale
2025-03-12	SELL	-1,805	68.510*	70.87 Profit of 127,923 on sale
2025-03-07	BUY	323	70.330*	70.94
2025-02-28	SELL	-969	71.620*	70.89 Profit of 68,697 on sale
2025-02-25	BUY	3,220	71.450*	70.86
2025-02-20	BUY	2,254	74.710*	70.74
2025-02-19	BUY	966	74.670*	70.68
2025-02-18	BUY	644	75.670*	70.60
2025-02-13	BUY	1,605	76.000*	70.32
2025-02-04	BUY	1,284	71.330*	70.12
2025-01-31	BUY	321	72.450*	70.05
2025-01-29	BUY	321	71.130*	69.97
2025-01-27	BUY	642	69.200*	69.93
2025-01-24	BUY	321	68.990*	69.95
2025-01-22	BUY	1,284	69.040*	69.99
2024-12-10	SELL	-322	73.390*	69.48 Profit of 22,372 on sale
2024-12-09	SELL	-8,372	70.900*	69.43 Profit of 581,299 on sale
2024-12-03	SELL	-3,864	70.200*	69.05 Profit of 266,826 on sale
2024-12-02	SELL	-1,610	70.530*	69.00 Profit of 111,089 on sale
2024-11-29	SELL	-3,235	71.350*	68.91 Profit of 222,921 on sale
2024-11-22	SELL	-3,250	70.480*	68.30 Profit of 221,960 on sale
2024-11-21	SELL	-1,625	70.380*	68.19 Profit of 110,810 on sale
2024-11-20	BUY	2,600	69.540*	68.12
2024-11-18	SELL	-3,900	69.890*	67.89 Profit of 264,785 on sale
2024-11-11	BUY	2,925	66.700*	68.11
2024-11-08	SELL	-10,336	66.230*	68.25 Profit of 705,395 on sale
2024-11-07	SELL	-644	65.840*	68.43 Profit of 44,070 on sale
2024-11-01	SELL	-644	67.540*	69.24 Profit of 44,591 on sale
2024-10-31	SELL	-1,300	67.010*	69.52 Profit of 90,374 on sale
2024-10-30	BUY	325	68.630*	69.65
2024-10-29	BUY	1,950	69.370*	69.69
2024-10-28	SELL	-975	68.520*	69.93 Profit of 68,178 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of EW

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	406,402	0	1,881,727	21.6%
2025-09-18	684,520	1,177	3,487,981	19.6%
2025-09-17	484,322	210	1,603,065	30.2%
2025-09-16	811,953	856	2,055,937	39.5%
2025-09-15	611,012	104	1,391,882	43.9%
2025-09-12	982,928	1,100	2,234,227	44.0%
2025-09-11	514,234	828	1,919,009	26.8%
2025-09-10	669,705	149	1,567,941	42.7%
2025-09-09	441,493	0	925,375	47.7%
2025-09-08	632,587	672	1,251,939	50.5%
2025-09-05	334,037	300	934,006	35.8%
2025-09-04	380,318	0	871,931	43.6%
2025-09-03	701,943	459	1,170,966	59.9%
2025-09-02	397,396	53	1,208,872	32.9%
2025-08-29	397,628	800	844,318	47.1%
2025-08-28	604,087	4	1,056,653	57.2%
2025-08-27	493,608	822	875,886	56.4%
2025-08-26	480,268	0	868,213	55.3%
2025-08-25	796,556	0	1,181,258	67.4%
2025-08-22	552,739	1	1,011,678	54.6%
2025-08-21	873,044	798	1,597,742	54.6%
2025-08-20	847,847	38,699	1,560,105	54.3%
2025-08-19	613,349	33	1,256,577	48.8%
2025-08-18	668,719	439	1,642,759	40.7%
2025-08-15	369,455	513	826,723	44.7%
2025-08-14	514,202	6,112	864,593	59.5%
2025-08-13	567,857	299	1,347,264	42.1%
2025-08-12	547,773	12,316	1,428,277	38.4%
2025-08-11	487,823	0	1,152,630	42.3%
2025-08-08	661,697	20	1,224,458	54.0%
2025-08-07	669,931	982	1,297,469	51.6%
2025-08-06	880,028	413	1,551,659	56.7%
2025-08-05	661,933	8	1,592,649	41.6%
2025-08-04	572,165	268	1,310,044	43.7%
2025-08-01	678,028	5,600	1,308,863	51.8%
2025-07-31	831,401	249	1,817,975	45.7%
2025-07-30	1,305,016	693	2,481,808	52.6%
2025-07-29	1,129,154	58	2,399,223	47.1%
2025-07-28	684,101	2,111	2,276,892	30.0%
2025-07-25	1,669,752	920	6,616,259	25.2%
2025-07-24	455,593	0	2,607,898	17.5%
2025-07-23	444,645	0	1,978,110	22.5%
2025-07-22	447,883	511	2,702,925	16.6%
2025-07-21	568,293	27	1,249,727	45.5%
2025-07-18	590,448	59	2,118,402	27.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares S&P 500 Health Care Sector UCITS ETF USD (Acc)
Issuer	Blackrock
Entity holding fund	iShares V Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300QETNU1W5JY7Z94
ETF Ticker	IHCU(GBX) LSE
ETF Ticker	IUHC(USD) LSE
ETF Ticker	QDVG(EUR) F
ETF Ticker	IHCU.LS(GBX) CXE
ETF Ticker	IUHC.LS(USD) CXE
ETF Ticker	IUHCz(USD) CXE
ETF Ticker	QDVG.DE(EUR) CXE
ETF Ticker	IHCU.L(GBP) LSE
ETF Ticker	IUHC.L(GBP) LSE